MYC and acute myeloid leukemia: In acute myeloid leukemia (AML), IMP2 stabilizes key mRNAs, including MYC, GPT2, and SLC1A5, that are essential for glutamine uptake and metabolism, fueling the TCA cycle and supporting AML cell proliferation and survival [113].